St. Jude researchers released AdaptiveFlow, an open-source AI platform that can screen huge libraries of drug-like molecules at far lower computing cost. Making large-scale searches easier could help more teams pursue difficult cancer targets.
Read more: https://www.eurekalert.org/news-releases/1142330
#cancerresearch — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #cancerresearch, aggregated by home.social.
-
-
Inspired by this @hackaday article (https://hackaday.com/2026/10/06/smalltv-hacking-with-surprisingly-little-fuss/) I decided to build my own library.
https://github.com/MarquisdeGeek/GeekMagicTV
First use case, display the sponsorship for this evening's charity walk!
(Even though our goal is met, you can still donate, here!)
https://fundraise.cancerresearchuk.org/page/stevens-giving-page-101755
-
Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women
Study population Between 27 November 2024 and 31 January 2025, adult women (female sex at birth) were recruited…
#NewsBeep #News #Medication #AU #Australia #Biomedicine #CancerResearch #general #Health #Healthcare #infectiousdiseases #MetabolicDiseases #MolecularMedicine #Neurosciences #Riskfactors
https://www.newsbeep.com/au/930618/ -
Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women
Study population Between 27 November 2024 and 31 January 2025, adult women (female sex at birth) were recruited…
#NewsBeep #News #Medication #Biomedicine #CancerResearch #general #Health #Healthcare #InfectiousDiseases #MetabolicDiseases #MolecularMedicine #Neurosciences #Riskfactors #UK #UnitedKingdom
https://www.newsbeep.com/uk/804781/ -
https://www.europesays.com/uk/1257056/ Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women #Biomedicine #CancerResearch #general #Health #HealthCare #InfectiousDiseases #Medication #MetabolicDiseases #MolecularMedicine #Neurosciences #RiskFactors #UK #UnitedKingdom
-
https://www.europesays.com/ie/737842/ Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women #Biomedicine #CancerResearch #Éire #general #Health #HealthCare #IE #InfectiousDiseases #Ireland #Medication #MetabolicDiseases #MolecularMedicine #Neurosciences #RiskFactors